AC Immune (ACIU) Total Current Liabilities (2015 - 2025)

AC Immune (ACIU) has 11 years of Total Current Liabilities data on file, last reported at $118.5 million in Q4 2025.

• Quarterly Total Current Liabilities rose 2.93% year-over-year to $118.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $118.5 million (up 2.93% YoY) and the FY2025 annual result came in at $114.2 million, down 0.78% from the prior year.
• Total Current Liabilities eased to $118.5 million in Q4 2025 per ACIU's latest filing, from $122.9 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $21.7 billion in Q4 2021 and bottomed at $11.6 million in Q1 2023.
• The 5-year median for Total Current Liabilities is $113.1 million (2024), against an average of $3.9 billion.
• The widest annual swing landed in 2021, when Total Current Liabilities surged 139962.65%; it then tumbled 99.95% in 2022.
• Tracing ACIU's Total Current Liabilities over 5 years: stood at $21.7 billion in 2021, then sank by 99.95% to $11.9 million in 2022, then surged by 128323.97% to $15.3 billion in 2023, then sank by 99.25% to $115.1 million in 2024, then climbed by 2.93% to $118.5 million in 2025.
• Per Business Quant, the three latest ACIU Total Current Liabilities figures stand at $118.5 million (Q4 2025), $122.9 million (Q3 2025), and $119.5 million (Q2 2025).

Peer Comparison